(Q39952790)

English

Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

Shouwei Li

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Wei Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Baoshi Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tao Jiang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Zhongcheng Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

21 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Neurological Research

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

690-694

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Treatment of glioblastoma multiforme: a new standard

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Changing paradigms--an update on the multidisciplinary management of malignant glioma

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Properties of mammalian O6-alkylguanine-DNA transferases

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

p53 Signaling and cell cycle checkpoints

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Mechanisms of disease: temozolomide and glioblastoma--look to the future

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Influence of p53 mutations on prognosis of patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

The challenge of p53 as prognostic and predictive factor in gliomas

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://api.crossref.org/works/10.1179%2F016164109X12478302362536

21 January 2018

Identifiers

10.1179/016164109X12478302362536

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39952790&oldid=1880848185"